100 % Datengenauigkeit
Wissenschaftlicher Support rund um die Uhr
0 % Toleranz bei der Produktqualität
Lagerstandorte
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Vorbehaltlich Verfügbarkeit
Dokumentation
Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.
80685-22-9Acyclovir Impurity 6
● Auf Lager
| Katalog-Nr.:: | VE007787 |
|---|---|
| CAS-Nr.:: | 80685-22-9 |
| Summenformel:: | C8H9N5O4 |
| Molare Masse:: | 239.19 g/mol |
Zusätzliche Informationen zu CAS 80685-22-9
Parent drug
AcyclovirIUPAC-Name
2-((2-amino-6-oxo-1, 6-dihydro-9H-purin-9-yl)methoxy)acetic acidPharmakopöe-Synonyme
N/AOther Synonyms
2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]acetic acid; 2-((2-Amino-6-oxo-1H-purin-9(6H)-yl)methoxy)acetic acid; Acetic acid,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-; 2-[(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)methoxy]acetic acid; Acetic acid, ((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-SMILES
C1=NC2=C(N1COCC(=O)O)N=C(NC2=O)NBeschreibung
It is a putative neurotoxin and the main metabolite of Acyclovir that has been used in the treatment and prophylaxis of infections with herpes simplex virus and varicella-zoster virus.References
Hellden, A., et al. “High Serum Concentrations of the Acyclovir Main Metabolite 9-Carboxymethoxymethylguanine in Renal Failure Patients with Acyclovir-Related Neuropsychiatric Side Effects: An Observational Study.†Nephrology Dialysis Transplantation, vol. 18, no. 6, June 2003, pp. 1135–41, https://doi.org/10.1093/ndt/gfg119. Darville, J. M., et al. “Development, Evaluation and Application of an Isocratic High-Performance Liquid Chromatography (HPLC) Assay for the Simultaneous Determination ofAngebot anfordern
„*“ zeigt erforderliche Felder an
Other products related to Acyclovir impurities
Verunreinigungsstruktur
Name der Muttersubstanz
CAS-Nr.:
Name der Verunreinigung
Katalog-Nr.:
Acyclovir/ Valaciclovir/ Valganciclovir/ Ganciclovir
CAS No. 73-40-5
Cat No. VL13014
